abstract |
The present invention relates to Tumor Necrosis Factor-alpha (TNF-alpha or TNF-.alpha.) inhibiting peptides and pro-cess for the preparation thereof. The present invention further relates to a pharmaceutical composition comprising TNF-alpha in-hibiting peptides of the present invention and uses thereof in treating TNF - alpha mediated inflammatory disorders. |